GEN Exclusives

More »
New Products

Related to Going to the Dogs

    • DNA Reference Standard
    • Horizon Discovery
    • The Quantitative Multiplex DNA reference standard is intended for researchers assessing multiple biomarkers in a single assay using platforms such as next-generation sequencing. It can enable researchers to quantify a range of detection thresholds
    • Stabilized Pepsin
    • SciGene
    • CytoZyme™ stabilized pepsin is an advanced formulation for pretreating tissue samples in nucleic acid probe-based cytogenetic assays including FISH. CytoZyme is a ready-to-use solution of purified pepsin that can be stored in the refrigerator witho
    • Sequencing System
    • Pacific Biosciences
    • The PacBio RS II allows scientists to generate finished genome assemblies, reveal and understand epigenomes, and characterize genomic variation. Based on the SMRT sequencing technology, the RS II can generate average read lengths of 5,000 base pair
    • qRT-PCR Assay
    • Life Technologies
    • Offered in partnership with Harvard University, the TaqMan® hPSC Scorecard™ panel and accompanying software is a qRT-PCR assay that integrates gene expression analysis with bioinformatics for a scorecard for the cells in question. The hPSC Sco
    • Kits for Analyzing Modified Cytosines
    • Cambridge Epigenetix
    • TrueMethyl™ kits provide quantitative, accurate and repeatable single-base resolution sequencing of the modified bases hydroxymethylcytosine (5-hmC) and methylcytosine (5-mC) in genomic DNA. This capability is attributable to the kits’ utiliza
  • Page 1 of 1 (5 items) 1 

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?